|
| |
Agilent Technologies Introduces First Gene Expression Bioinformatics
System Offering Guided Workflows
Users Make Simple Choices and Receive Step-By-Step Guidance to Shorten
Learning Curve
SANTA CLARA, Calif., Feb. 19, 2008 -- Agilent Technologies Inc., (NYSE: A),
today introduced GeneSpring GX 9.0. This edition of Agilent’s leading
visualization and analysis system for gene expression data includes new guided
workflow features for major microarray platforms, helping new users quickly
produce results.
“GeneSpring GX is considered the gold standard in desktop expression analysis,
and we introduced the concept of ‘guided workflows’ to make all of this power
easily accessible to a wider group of scientists,” said Thon de Boer, Agilent
GeneSpring product manager. “Now, the user is guided through choices that lead
to better results, faster than ever.”
GeneSpring GX 9.0 offers gene expression guided workflows for Agilent SurePrint
microarrays, Affymetrix(r) GeneChips and Illumina Beadchips, with additional
applications planned.
GeneSpring GX 9.0 also provides an advanced mode, offering full control over the
complete set of features for all array types and technologies.
Advanced Statistical Tools
GeneSpring GX 9.0 enables users to ask detailed questions about complex data
sets, including t-tests, two-way and three-way ANOVA tests, and one-way post-hoc
tests for reliably identifying differentially expressed genes. The system’s
class-prediction analysis tools help users identify genes capable of
discriminating between one or more experimental parameters or sample phenotypes.
Scientists can employ a broad assortment of pattern-recognition techniques to
uncover the most abundant patterns in gene expression data, and to recognize how
those patterns are related. Gene trees, experiment trees, self-organizing maps
and a variety of k-means clustering metrics are provided in GeneSpring GX 9.0.
After statistical analysis, GeneSpring GX 9.0 can be used to highlight enriched
pathways or gene ontology categories for insight into how the data relates to
the biology. The system supports the BioPAX pathways/network exchange format
(OWL) and lets users import hundreds of networks and pathways from a large
number of sources such as KEGG (requires license), The Cancer Cell Map and
BioCyc.
This is the first GeneSpring release on the Avadis platform, developed by Strand
Life Sciences under an agreement announced in August 2007. More details are
available at www.chem.agilent.com
under “Informatics and Software.”
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world’s premier measurement company
and a technology leader in communications, electronics, life sciences, and
chemical analysis. The company’s 19,000 employees serve customers in more than
110 countries. Agilent had net revenues of $5.4 billion in fiscal
2007. Information about Agilent is available on the Web at
www.agilent.com .
# # #
Affymetrix is a U.S. registered trademark of Affymetrix Inc.
NOTE TO EDITORS: Further technology, corporate citizenship and executive news is
available on the Agilent news site at
www.agilent.com/go/news .
Press release URL:
http://www.agilent.com/about/newsroom/presrel/2008/14feb-ca08009.html
Additional metadata keywords (for Web use only): GeneSpring GX, gene expression,
bioinformatics, guided workflows
--end--
PRCA08009
EDITORIAL CONTACTS:
Claudia Hachtel, Agilent Technologies
Nicki Muir, Alto Marketing
+49-7243-602 100
+44-1489-55 76 72
claudia_hachtel@agilent.com
nickim@alto-marketing.com
Sarah Perceval, Alto Marketing
+44-1489-55 76 72
sarahp@alto-marketing.com
| |
|
